Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing and able to sign a consent form agreeing to take part
• You are 18 years old or older (any gender)
• You have been diagnosed with gastrointestinal cancer or breast cancer (confirmed by a lab/pathology test) and are about to receive the chemotherapy drug capecitabine for the first time
• Your general health and ability to carry out daily activities meets a certain standard (rated 0–2 on a standard scale used by doctors — confirm with trial site)
• You are receiving capecitabine as part of palliative or adjuvant chemotherapy (either alone or combined with other drugs), at a minimum daily dose of 2000 mg/m² (confirm with trial site)
• Your doctors expect you to live for at least 3 more months
• Your blood test results are within acceptable ranges — including healthy levels of platelets, white blood cells, and hemoglobin, and your liver and kidneys are functioning normally
• You are using adequate contraception if applicable

Who may not be able to join:

• You have previously been treated with capecitabine, liposomal doxorubicin, or certain other targeted therapy drugs (such as sorafenib, sunitinib, or apatinib) that can cause a side effect called hand-foot syndrome
• Your starting dose of capecitabine is below a certain level (less than 800 mg/m² — confirm with trial site)
• You have had radiation therapy or surgery within the 4 weeks before the trial treatment begins
• You have a skin condition that could affect the trial results
• You have a known problem with drug or alcohol misuse
• You are pregnant or currently breastfeeding
• You are already taking part in another clinical trial and have received an experimental drug within the last 30 days before the start of this trial's treatment
• You are known to be afraid of electroacupuncture (a type of needle-based treatment used in this trial), or you are allergic to stainless steel needles or any ingredient in capecitabine
• You are currently receiving acupuncture or moxibustion treatment, or you have lymph fluid build-up (lymphedema) in the area where acupuncture needles would be placed
• You still have side effects from previous chemotherapy or radiotherapy that have not improved to a mild level (grade 2 or below), except for certain stable nerve-related symptoms
• You have any unresolved skin side effects from previous chemotherapy or radiotherapy (hair loss is an exception to this rule)

Important: Always verify eligibility with the trial site directly before applying.